As a young, dynamic and creative molecular diagnostics company, we have specialized in simple and rapid solutions for the diagnosis of severe infectious diseases in hospitalized patients. We help to combat infections effectively and detect antibiotic resistance at an early stage.
MGI and Curetis to Collaborate on NGS-based Infectious Disease Diagnostics
Curetis Announces Financial Results for the First Six Months of 2017
European Meeting on Molecular Diagnostics - Noordwijk, Netherlands - October 11 to 13, 2017
ID Week - Advancing Science, Improving Care, San Diego, CA, USA - October 4 to 8, 2017